Pharming Group share price logo

Pharming Group

NASDAQ: PHAR

Small Cap

$11.72

-0.06

(-0.51%)

Live

as on

Pharming Group Stock Performance

as on August 29, 2026 at 1:08 am IST

  • $11.72
    $11.72
  • 52 Week's Low

    52 Week's High

    $9.62
    $21.34
    downward going graph

    17.92%

    Downside

    82.08%

    Upside

    downward going graph

Pharming Group share price movements today

Previous Close
$11.78
Open
$11.72
Volume
16.8K
Market Cap
$845.8M
Day's Low - High
$11.72 - $11.72
52 Week Low - High
$9.62 - $21.34

Pharming Group Historical Returns

1 Month Return
-8.4 %
3 Month Return
-13.76 %
1 Year Return
-19.26 %
3 Year Return
-4.19 %
5 Year Return
+ 11.66 %

Pharming Group Stock Fundamentals & Key Indicators

Check Pharming Group market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$845.8M

EPS (TTM)

0.138

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.63%

PE Ratio (TTM)

79.86

Industry PE ratio

-5.406459627329193

PEG Ratio

0.0027148147737807507

EBITDA

42.6M

Revenue (TTM)

366.4M

Profit Margin

86.50%

Return On Equity TTM

3.50%

Pharming Group Stock Valuation

Track how Pharming Group P/E has moved over time to understand its valuation trends.

Pharming Group in the last 5 years

  • Overview

  • Trends

Lowest (-71.20x)

December 31, 2023

Industry (-5.41x)

December 31, 2025

Today (441.75x)

December 31, 2025

Highest (441.75x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: 441.75x

Pharming Group vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pharming Group with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$845.8M11.66%79.8686.50%NA
BUY$46.2B675.69%NA0.00%NA
BUY$138.7B173.88%31.9286.04%NA
BUY$59.7B-62.65%-7.98-12.57%NA
BUY$85.8B21.77%19.984.86%0.44%

Stock Returns calculator for Pharming Group Stock including INR - Dollar returns

The Pharming Group stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Pharming Group investment value today

Current value as on today

₹87,461

Returns

-₹12,539

(-12.54%)

Returns from Pharming Group Stock

-₹19,671 (-19.67%)

Dollar Impact

₹7,132 (+7.13%)

Analyst Recommendation on Pharming Group Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Pharming Group. Average target price of $34.35

Pharming Group Share Price Target

Get share price movements and forecasts by analysts on Pharming Group.

What analysts predicted

65.88%UPSIDE

Target Price

$34.35

Current Price

$11.72

Analyzed by

2 Analysts

Target

$34.35

Pharming Group target price $34.35, a slight upside of 65.88% compared to current price of $11.72. According to 2 analysts rating.

Indian Investors' Interest in Pharming Group Stock

Search interest for Pharming Group Stock has decreased by -8% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-8% versus previous 30 day period

Pharming Group Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
55
74
74
92,700
79
93
97
106
72
90
Gross Profit
47
66
68
80,500
70
84
90
85
65
75
Operating Income
-16
-3
3
6,600
-7
9
15
2
-5
0
EBITDA
-9
1
7
6,707
-4
9
23
9
1
8
Interest Expense
1
1
2
1
5
0
7
1
2
2
Depreciation
5
-
2
7
2
2
2
3
3
3
Income Before Tax
-16
0
1
6,700
-11
7
12
4
-4
3
Income Tax Expense
-4
1
2
3,800
3
2
5
0
0
1
Net Income
-12
-1
-1
2,900
-14
4
7
5
-5
1
Net Profit Margin
84.91%
89.20%
90.89%
86.82%
89.48%
90.38%
92.73%
80.19%
90.83%
83.88%

Pharming Group Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
107
154
189
212
198
205
245
297
376
Gross Profit
92
129
165
188
177
188
220
261
330
Operating Income
26
43
68
76
19
9
-22
-3
20
EBITDA
-76
24
71
58
48
33
9
16
34
Interest Expense
45
16
13
10
7
5
5
9
10
Depreciation
4
7
5
8
19
13
15
16
11
Income Before Tax
-102
0
52
44
23
14
-12
-8
12
Income Tax Expense
-11
-27
11
6
7
1
-1
3
10
Net Income
-91
28
40
37
15
13
-10
-11
2
Net Profit Margin
86.11%
83.59%
87.37%
88.91%
89.37%
91.46%
89.72%
88.09%
87.90%

Pharming Group Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-16
0
1
6
-11
7
12
4
-4
3
Operating Cash Flow
-7
-13
9
9
0
11
32
10
1
-12
Investing Cash Flow
0
36
4
-9
9
16
0
0
-84
0
Financing Cash Flow
-2
-28
-1
-2
-6
-2
9
1
-9
0
Change in Cash
-9
-4
13
-5
5
31
40
12
-92
105

Pharming Group Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
26
0
52
44
23
14
-12
-8
12
Operating Cash Flow
45
46
74
83
37
22
-17
-1
54
Investing Cash Flow
-7
-4
-28
-15
-21
5
-129
31
26
Financing Cash Flow
-3
-20
-63
60
-27
-4
-1
-34
1
Change in Cash
33
24
-17
130
-13
15
-145
-6
90

Mutual Funds that own Pharming Group Stock

Check out the Mutual Funds with significant holdings in Pharming Group.

Funds
Holdings
Shares Held
Steward Funds Inc
0.017608%
12463
Fidelity Concord Street Trust
0.002957%
2093

Global Institutional Holdings in Pharming Group

Funds
Holdings
EverSource Wealth Advisors, LLC
0%
Nalls Sherbakoff Group, LLC
0%
Cornerstone Financial Management, LLC
0%
Goss Wealth Management LLC
0%
Coldstream Capital Management Inc
0%

Insights on Pharming Group

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 72.44M → 90.21M (in $), with an average increase of 19.7% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -5.21M → 1.63M (in $), with an average increase of 418.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 25.4% return, outperforming this stock by 29.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 483.4% return, outperforming this stock by 502.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, PHAR stock has moved down by -8.4%

About Pharming Group

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops Joenja, an oral small molecule PI3K" inhibitor. It has a development collaboration and license agreement with Novartis. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.
OrganisationPharming Group
HeadquartersDarwinweg 24, Leiden, Netherlands, 2333 CR
IndustryBiotechnology
CEOMr. Fabrice Chouraqui M.B.A., Ph.D., Pharm.D.
E-voting on sharesClick here to vote

Key Management of Pharming Group

Name

Title

Mr. Ruud Van Outersterp L.L.M.

Chief Legal & Compliance Officer and Company Secretary

Ms. Ines Bernal B.A.

Chief People Officer

Dr. Alexander Breidenbach M.B.A., Ph.D.

Chief Business Officer

Ms. Leverne Marsh BPHARM

Chief Commercial Officer

Dr. Magnus Hansson

Medical Director

Mr. Fabrice Chouraqui M.B.A., Ph.D., Pharm.D.

CEO & Executive Director

Mr. Kenneth Lynard EMBA, M.Sc.

Chief Financial Officer

Ms. Mireille Sanders M.Sc.

Chief Operations Officer

Mr. Michael K. Levitan

VP of Investor Relations & Corporate Communications

Dr. Anurag Relan M.D., MPH

Chief Medical Officer

FAQs

What is Pharming Group share price today?

Pharming Group share price today is $11.72 as on . Pharming Group share today touched a day high of $11.72 and a low of $11.72.

What is the 52 week high and 52 week low for Pharming Group share?

Pharming Group share touched a 52 week high of $21.34 on and a 52 week low of $9.62 on . Pharming Group stock price today i.e. is trending at $11.72,which is 45.08% down from its 52 week high and 21.83% up from its 52 week low.

What is Pharming Group's market capitalisation today?

Pharming Group market capitalisation is $0.00T as on .

How to invest in Pharming Group Stock (PHAR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Pharming Group on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pharming Group Shares that will get you 0.1280 shares as per Pharming Group share price of $11.72 per share as on August 28, 2026 at 7:38 pm IST.

What is the minimum amount required to buy Pharming Group Stock (PHAR) from India?

Indian investors can start investing in Pharming Group (PHAR) shares with as little as ₹95.368 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.68 in Pharming Group stock (as per the Rupee-Dollar exchange rate as on ). Based on Pharming Group share’s latest price of $11.72 as on August 28, 2026 at 7:38 pm IST, you will get 0.8532 shares of Pharming Group. Learn more about fractional shares .

What are the returns that Pharming Group has given to Indian investors in the last 5 years?

Pharming Group stock has given 11.66% share price returns and 30.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?